It was discovered in CD133+ SCLC cells, an increased expression of the mitogenic neuropeptide receptors for a gastrin-releasing peptide and arginine-vasopressin (Sarvi et al., 2014). This evidence concerns the gene PROM1 and small cell lung carcinoma.